ESR1 and cancer: When examined by ER positivity, a high G2M pathway score was associated with shorter metastasis-free survival only in ER-positive cancer, although the ER-negative sample size was small in GSE2034 cohort, and the ER status of the primary tumors was unavailable for the other cohort (Figure 3B).